新聞BioAmber Inc. invests into assets: plant in the amount of $140M.BioAmber attracted $52 million in federal and provincial funding to help build the $140-million plant, which was touted as an early success for Sarnia’s efforts to attract biochemical manufacturers alongside its traditional petrochemical companies.
新聞BioAmber Inc. is developing 1,4-Butanediol on the site.BioAmber also plans to produce 1,4-Butanediol (BDO) on the site, using technology exclusively licensed from DuPont that coverts succinic acid to BDO, a chemical with a $4 billion existing market.
新聞BioAmber Inc. launches BIO-SA pharmaceutical-grade bio-based succinic acid.BioAmber Inc. had launched BIO-SA pharmaceutical-grade bio-based succinic acid, which is manufactured under the US Food and Drug Administration (FDA) good manufacturing practices (GMP) applicable to food and excipients.
